Ionis Pharmaceuticals (IONS) PT Lowered to $65 at RBC Capital After Tominersen Phase III Study was Discontinued

Go back to Ionis Pharmaceuticals (IONS) PT Lowered to $65 at RBC Capital After Tominersen Phase III Study was Discontinued
(NASDAQ: IONS) Delayed: 57.24 +1.37 (2.45%)
Previous Close $55.87    52 Week High $62.68 
Open $55.16    52 Week Low $19.59 
Day High $57.24    P/E N/A 
Day Low $55.16    EPS $0.00 
Volume 1,353,738       

UNIQURE (NASDAQ: QURE) Delayed: 48.62 +1.56 (3.31%)
Previous Close $47.06    52 Week High $22.79 
Open $47.06    52 Week Low $6.63 
Day High $48.70    P/E N/A 
Day Low $46.31    EPS $0.00 
Volume 957,689       

(NASDAQ: WVE) Delayed: 5.41 +0.21 (4.04%)
Previous Close $5.20    52 Week High $38.50 
Open $5.16    52 Week Low $8.95 
Day High $5.42    P/E N/A 
Day Low $5.14    EPS $0.00 
Volume 2,884,323